NASDAQ: PROK PROKIDNEY CORP. 8-K

ProKidney confirms mid-2026 Phase 3 enrollment completion, Q2 2027 pivotal results expected

Filed May 15, 2026 · Period ending May 15, 2026 · ~1 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade PROK commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 1, 2026 4:12 PM